Evolutionary trajectory of SARS-CoV-2 and emerging variants
The emergence of a novel coronavirus, severe acute respiratory syndrome coronavirus 2
(SARS-CoV-2), and more recently, the independent evolution of multiple SARS-CoV-2 …
(SARS-CoV-2), and more recently, the independent evolution of multiple SARS-CoV-2 …
The immunology of asymptomatic SARS-CoV-2 infection: what are the key questions?
RJ Boyton, DM Altmann - Nature Reviews Immunology, 2021 - nature.com
An important challenge during the COVID-19 pandemic has been to understand
asymptomatic disease and the extent to which this may be a source of transmission. As …
asymptomatic disease and the extent to which this may be a source of transmission. As …
Just 2% of SARS-CoV-2− positive individuals carry 90% of the virus circulating in communities
Q Yang, TK Saldi, PK Gonzales… - Proceedings of the …, 2021 - National Acad Sciences
We analyze data from the fall 2020 pandemic response efforts at the University of Colorado
Boulder, where more than 72,500 saliva samples were tested for severe acute respiratory …
Boulder, where more than 72,500 saliva samples were tested for severe acute respiratory …
Analysis of the COVID-19 pandemic: lessons towards a more effective response to public health emergencies
Abstract Background The pandemic of Coronavirus Disease 2019 (COVID-19) is a timely
reminder of the nature and impact of Public Health Emergencies of International Concern …
reminder of the nature and impact of Public Health Emergencies of International Concern …
Patterns of seroconversion for SARS-CoV-2 IgG in patients with malignant disease and association with anticancer therapy
Patients with cancer have been identified in several studies to be at high risk of developing
severe COVID-19; however, rates of SARS-CoV-2 IgG seroconversion and its association …
severe COVID-19; however, rates of SARS-CoV-2 IgG seroconversion and its association …
The importance of understanding the stages of COVID-19 in treatment and trials.
DO Griffin, D Brennan-Rieder, B Ngo, P Kory… - AIDS …, 2021 - search.ebscohost.com
Abstract COVID-19, caused by SARS-CoV-2, continues to be a major health problem since
its first description in Wuhan, China, in December 2019. Multiple drugs have been tried to …
its first description in Wuhan, China, in December 2019. Multiple drugs have been tried to …
[HTML][HTML] Positive impact of oral hydroxychloroquine and povidone-iodine throat spray for COVID-19 prophylaxis: an open-label randomized trial
RCS Seet, AML Quek, DSQ Ooi, S Sengupta… - International Journal of …, 2021 - Elsevier
Background We examined whether existing licensed pharmacotherapies could reduce the
spread of coronavirus disease 2019 (COVID-19). Methods An open-label parallel …
spread of coronavirus disease 2019 (COVID-19). Methods An open-label parallel …
[HTML][HTML] Herd immunity against severe acute respiratory syndrome coronavirus 2 infection in 10 communities, Qatar
We investigated what proportion of the population acquired severe acute respiratory
syndrome coronavirus 2 (SARS-CoV-2) infection and whether the herd immunity threshold …
syndrome coronavirus 2 (SARS-CoV-2) infection and whether the herd immunity threshold …
A potential association between obesity and reduced effectiveness of COVID‐19 vaccine‐induced neutralizing humoral immunity
Due to the adverse effects of obesity on host immunity, this study investigated the
effectiveness of COVID‐19 vaccines (BNT162b2, ChAdOx‐nCov‐2019, and mRNA‐1273) in …
effectiveness of COVID‐19 vaccines (BNT162b2, ChAdOx‐nCov‐2019, and mRNA‐1273) in …
Artificial intelligence in surveillance, diagnosis, drug discovery and vaccine development against COVID-19
As of August 6th, 2021, the World Health Organization has notified 200.8 million laboratory-
confirmed infections and 4.26 million deaths from COVID-19, making it the worst pandemic …
confirmed infections and 4.26 million deaths from COVID-19, making it the worst pandemic …